Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles
To fully utilize the potential of CRISPR-Cas9-mediated genome editing, time-restricted and targeted delivery is crucial. By modulating the pseudotype of engineered lentivirus-derived nanoparticles (LVNPs), we demonstrate efficient cell-targeted delivery of Cas9/single guide RNA (sgRNA) ribonucleopro...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-12-01
|
| Col·lecció: | Molecular Therapy: Nucleic Acids |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2162253124002051 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
